Seizert Capital Partners’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-105,543
Closed -$12.6M 188
2020
Q4
$12.6M Sell
105,543
-11,183
-10% -$1.36M 0.73% 47
2020
Q3
$13.4M Sell
116,726
-27,956
-19% -$3.3M 0.88% 43
2020
Q2
$16.5M Sell
144,682
-93,905
-39% -$9.96M 1.12% 37
2020
Q1
$19.2M Buy
238,587
+108,821
+84% +$11.3M 1.41% 32
2019
Q4
$13.9M Sell
129,766
-34,945
-21% -$3.64M 0.69% 44
2019
Q3
$17.6M Sell
164,711
-4,404
-3% -$452K 0.89% 41
2019
Q2
$17.2M Sell
169,115
-39,548
-19% -$3.8M 0.85% 41
2019
Q1
$18.8M Sell
208,663
-74,287
-26% -$6.44M 0.84% 46
2018
Q4
$23.6M Buy
282,950
+7,845
+3% +$735K 1.06% 44
2018
Q3
$29.7M Sell
275,105
-81,289
-23% -$8.92M 1.09% 37
2018
Q2
$35.7M Hold
356,394
1.3% 32
2018
Q1
$35.7M Sell
356,394
-14,074
-4% -$1.44M 1.3% 32
2017
Q4
$36.5M Buy
370,468
+24,488
+7% +$2.32M 1.31% 34
2017
Q3
$32.4M Buy
345,980
+43,996
+15% +$4.67M 1.19% 37
2017
Q2
$33.6M Sell
301,984
-18,646
-6% -$1.97M 1.21% 36
2017
Q1
$31.5M Buy
+320,630
New +$30.6M 1.12% 37

Other funds holding DGX

Seizert Capital Partners's DGX Position: Q1 2021 in Review

Seizert Capital Partners sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 105,543 shares — an estimated $12.6M sold.

Seizert Capital Partners first reported a position in DGX in Q1 2017 and held it in 16 quarters. The position peaked at $36.5M in Q4 2017. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

  • Seizert Capital Partners reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Seizert Capital Partners sold 105,543 Quest Diagnostics shares in Q1 2021, an estimated $12.6M.
  • Seizert Capital Partners first reported a position in Quest Diagnostics in Q1 2017 and held it in 16 quarters.
  • Seizert Capital Partners's Quest Diagnostics position peaked at $36.5M in Q4 2017.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Seizert Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.